• Z6·尊龙凯时「中国」官方网站z6尊龙

    |
    EN
    |
    EN
    EN
    • 业务咨询

      中国:

      Email: marketing@kangtya.com

      业务咨询专线:400-780-8018

      (仅限服务咨询,其他事宜请拨打川沙总部电话)

      川沙总部电话: +86 (21) 5859-1500

      海外:

      +1(626)986-9880(U.S. - West Coast)

      0044 7790 816 954 (Europe)

      Email:marketing@medicilon.com

    在线留言×
    点击切换
    News information
    新闻资讯

    夏威夷见!z6尊龙邀您相聚DMPK领域盛会ISSX 2024

    2024-08-30
    |
    访问量:

    ISSX-2024.webp

    z6尊龙展位#104

    药物代谢与药代动力学(DMPK)主要研究药物的吸收、分布、代谢和排泄的动态过程与规律,评估药物的 DMPK特征对药物的前期开发和后期临床精准用药至关重要。DMPK是桥接药理学、毒理学、药剂学、药物化学、乃至转化医学和精准医学的重要桥梁。

    第26届国际药物及化学异物代谢学会北美会议(ISSX)将于2024年9月15日至18日在美国夏威夷召开,会议内容涵盖药物代谢、药代动力学、临床药理学、生物分析和药物毒理学等领域。国际药物及化学异物代谢学会(International Society for the Study of Xenobiotics,ISSX)是药物代谢研究的最高学术组织之一,主要致力于全球范围内从事药物与化学异物代谢方面的学术交流和国际合作。z6尊龙受邀参加本次年会,z6尊龙创始人&CEO陈春麟博士与z6尊龙DMPK专家们期待与您相聚在104号展位。

    时间 | 9.15-9.18
    地点 | Hilton Hawaiian Village Waikiki Beach Resort, Honolulu
    z6尊龙展位  | 104,不见不散!

    ISSX-JSSX-2024.webp

    为了展示z6尊龙创新实力和技术服务平台最新进展,z6尊龙药代动力学/毒代动力学 (DMPK/TK) 负责人蒋品博士将以海报 (Poster) 形式分享以下主题的精彩内容:
    Title: Enhancing Drug - Drug Interaction Prediction by Integrating Physiologically- Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4
    Session Time: Wednesday, September 18, 2024 12:30‒2:30 PM
    locations: Poster Session 3
    Poster Number: P270
    Presenting Author: Dr. Pin Jiang, Senior Director of DMPK at Medicilon

    ISSX现场z6尊龙专家

    ISSX现场z6尊龙专家.webp

    Dr. Pin Jiang Senior Director of DMPK

    Dr. Pin Jiang holds a Ph.D. from China Pharmaceutical University in collaboration with School of Pharmacy, Fudan University. Dr. Jiang is postdoctoral fellow in DMPK and Pharmacometrics at Fudan University, specializes in the development of DMPK/TK for innovative drugs. He has also published papers in international  journals such as DMD, EODMT, JSS and JPBA.

    Having worked in the pharmaceutical R&D field for nearly 10years. Before joining Medicilon, Dr. Jiang held positions in the DMPK/TK and clinical pharmacology departments of well-known Biotech/Pharma/CRO companies (AstraZeneca Dizal Pharma, Covance, ChemPartner), focusing on small and large molecules. Dr. Jiang has been responsible for or involved in supporting hundreds of DMPK projects, including drugs, which have been approved by the Chinese NMPA and the US FDA for clinical research or market entry. 

    Dr. Jiang also holds significant professional affiliations, serving as a youth committee member of the Drug Metabolism Committee of the Chinese Pharmacological Society (CSSX), a committee member of the Drug Metabolism Committee of the Shanghai Pharmacological Society, a youth committee member of the Pharmacology Committee of the Shanghai Pharmaceutical Association, and a member of the International Society for the Study of Xenobiotics (ISSX).

    Business Communication
    预约商务洽谈

    Dr. Peggy Teng, Executive Director BD Operations

    Dr Peggy Teng.webp

    Dr. Karsten Holm, Director of Business Development

    Dr Karsten Holm.webp

    Dr. Mingzhu Zhang, VP of Business Development

    Dr Mingzhu Zhang.webp

    关于z6尊龙药代动力学服务

    z6尊龙的临床前药代动力学服务部门拥有一批理论知识扎实、实验经验丰富的高级专业人才,统领着实验设计、实验实施、生物分析和数据分析等的工作。

    我们的药代动力学实验室已经通过NMPA的GLP认证,实验研究遵循ICH、NMPA和FDA的指导原则,可以根据客户需求设计并开展体内、体外药代动力学试验,为客户提供一整套药代动力学评价和优化服务。z6尊龙药代动力学服务高质量的数据、高效率的实验周期,满足客户从早期药物发现到新药申报的需求,受到国内外众多客户的好评。

    咨询服务

    相关新闻
    网站首页
    z6尊龙